Background illustration for clinical trials search

Paid Clinical Trials Tuscaloosa

Discover 870 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

for
Hematologic Malignancies
Location: Birmingham AL, Newnan GA, Greenville SC, Tampa FL,
Sponsor: Sellas Life Sciences Group

Sex: All

Age: 12+

Code: NCT04588922

Phase 1, Phase 2, Recruiting

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

for
Solid Tumor, Adult
Location: Birmingham AL, Tyler TX, Orlando FL, Chicago IL,
Sponsor: Corbus Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06265727

Phase 1, Phase 2, Recruiting

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

for
Clonal Mast Cell Disease, KIT D816V Mutation,
Location: Birmingham AL, Atlanta GA, New Orleans LA, St Louis MO,
Sponsor: Blueprint Medicines Corporation

Sex: All

Age: 18+

Code: NCT07143669

Recruiting

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

for
Locally Recurrent Skin Squamous Cell Carcinoma,
Location: Birmingham AL, Atlanta GA, Effingham IL, Mattoon IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07042295

Phase 2, Recruiting

MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial

for
Malignant Testicular Germ Cell Tumor
Location: Birmingham AL, Atlanta GA, Toronto, New Brunswick NJ,
Sponsor: University of Southern California

Sex: Male

Age: 18+

Code: NCT06060873

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

for
Metastatic Non-Squamous Non-Small Cell Lung Cancer,
Location: Birmingham AL, Durham NC, New York NY, Mineola NY,
Sponsor: CatalYm GmbH

Sex: All

Age: 18+

Code: NCT07246863

Phase 2, Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

for
Cervical Carcinoma, Human Papillomavirus Infection
Location: Birmingham AL, Atlanta GA, New Orleans LA, Lafayette LA,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 25+

Code: NCT07281430

Recruiting

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for
Locally Advanced Cervical Adenocarcinoma,
Location: Birmingham AL, Newnan GA, Atlanta GA, Decatur GA,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07061977

Phase 3, Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Birmingham AL, Collierville TN, Southhaven MS,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase 3, Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Birmingham AL, Newnan GA, Jackson MS, Germantown TN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07061964

Phase 2, Recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for
Core Binding Factor Acute Myeloid Leukemia
Location: Birmingham AL, Columbus MS, New Albany MS, Grenada MS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT06917911

Phase 2, Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

for
Endometrial Adenocarcinoma,
Location: Birmingham AL, Augusta GA, Louisville KY, St Louis MO,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05112601

Phase 2, Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for
Pancreatic Neoplasm
Location: Birmingham AL, Mobile AL, Atlanta GA, Nashville TN,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Birmingham AL, Metairie LA, Gainesville FL,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07000084

Phase 3, Recruiting

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

for
Castration-Resistant Prostate Carcinoma,
Location: Birmingham AL, Greer SC, Spartanburg SC, Union SC,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06632977

Phase 2, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: Birmingham AL, Columbus MS, New Albany MS, Grenada MS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase 2, Recruiting

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Birmingham AL, Gulfport MS, New Orleans LA, Metairie LA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04510597

Phase 3, Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: Birmingham AL, Columbus MS, New Albany MS, Grenada MS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase 2, Recruiting

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

for
Malignant Solid Neoplasm
Location: Birmingham AL, Atlanta GA, Hendersonville NC, Greer SC,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642611

Phase 3, Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Birmingham AL, Columbus MS, New Albany MS, Grenada MS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase 2, Recruiting